135 related articles for article (PubMed ID: 28589706)
21. Assessing protein and albumin recovery rates in different ascites filtration membrane washing methods for cell-free and concentrated ascites reinfusion therapy.
Yamada S; Nii N; Ohashi A; Hasegawa M; Yuzawa Y; Tsuboi N
Fujita Med J; 2024 May; 10(2):53-59. PubMed ID: 38708077
[TBL] [Abstract][Full Text] [Related]
22. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
23. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives.
; Matsusaki K; Ohta K; Yoshizawa A; Gyoda Y
Int J Clin Oncol; 2011 Aug; 16(4):395-400. PubMed ID: 21347629
[TBL] [Abstract][Full Text] [Related]
24. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
Shimizu S; Ohira M; Nakano R; Imaoka Y; Sato K; Tahara H; Ide K; Kobayashi T; Kuroda S; Ono H; Tanaka Y; Ohdan H
Transplant Proc; 2019 Oct; 51(8):2740-2744. PubMed ID: 31563243
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of cell-free and concentrated ascites reinfusion therapy (CART) in gynecologic cancer patients with a large volume of ascites.
Wang L; Okubo T; Shinsaka M; Kobayashi A; Ogasawara M; Sakaguchi R; Nagai T; Seki H
J Obstet Gynaecol Res; 2015 Oct; 41(10):1614-20. PubMed ID: 26177394
[TBL] [Abstract][Full Text] [Related]
26. A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites.
Orimi S; Mizuno K; Narahara M; Umakosi H; Kaihara M; Hashimoto M
Ther Apher Dial; 2011 Aug; 15(4):411-4. PubMed ID: 21884478
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
Ito T; Hanafusa N; Soneda N; Isoai A; Kobayashi R; Torii N; Kato M
J Gastroenterol Hepatol; 2021 Nov; 36(11):3224-3232. PubMed ID: 34250635
[TBL] [Abstract][Full Text] [Related]
28. CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.
Ito T; Hanafusa N
Transfus Apher Sci; 2017 Oct; 56(5):703-707. PubMed ID: 28916401
[TBL] [Abstract][Full Text] [Related]
29. Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.
Maeda O; Ando T; Ishiguro K; Watanabe O; Miyahara R; Nakamura M; Funasaka K; Kazuhiro F; Ando Y; Goto H
Mol Clin Oncol; 2014 Nov; 2(6):1103-1106. PubMed ID: 25279205
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis.
Chen H; Ishihara M; Horita N; Tanzawa S; Kazahari H; Ochiai R; Sakamoto T; Honda T; Ichikawa Y; Watanabe K; Seki N
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638357
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural observation of filtration membrane in cell-free and concentrated ascites reinfusion therapy for malignant ascites.
Koga K; Ishihara T; Doi Y; Suzuki R; Komatsu M; Abe K; Tanaka T; Iwaki R; Hashi H; Sugawara A
Ther Apher Dial; 2022 Jun; 26(3):649-657. PubMed ID: 34689425
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites.
Fukunaga S; Egawa M; Ito T; Tanabe K
J Artif Organs; 2024 Jun; 27(2):138-145. PubMed ID: 37178240
[TBL] [Abstract][Full Text] [Related]
33. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
[TBL] [Abstract][Full Text] [Related]
34. Large-volume cell-free and concentrated ascites reinfusion therapy improves venous flow in patients with liver cirrhosis.
Matsumoto N; Ogawa M; Kanda T; Matsuoka S; Moriyama M; Matsusaki K
J Med Ultrason (2001); 2021 Jul; 48(3):315-322. PubMed ID: 33835337
[TBL] [Abstract][Full Text] [Related]
35. [Cell-free and concentrated ascites reinfusion therapy(CART)].
Yoshizawa A; Gyouda Y; Ishiguro T; Matsuzaki K; Yoshizawa T
Gan To Kagaku Ryoho; 2012 Dec; 39 Suppl 1():33-5. PubMed ID: 23268893
[TBL] [Abstract][Full Text] [Related]
36. Comparison Between the Internal and External Pressure Filtration Method of Cell-Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites.
Yamada S; Hasegawa M; Nii N; Kato M; Ohashi A; Suzuki R; Komatsu M; Abe K; Hata Y; Takahashi K; Hayashi H; Koide S; Tsuboi N; Inaguma D; Yuzawa Y
Ther Apher Dial; 2019 Jun; 23(3):237-241. PubMed ID: 31025830
[TBL] [Abstract][Full Text] [Related]
37. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
[TBL] [Abstract][Full Text] [Related]
38. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
[TBL] [Abstract][Full Text] [Related]
39. [A Case of Concentrated Ascites Reinfusion Therapy(CART)for Abundant Refractory Ascites in Cecal Cancer with Peritoneal Dissemination Followed by the Readministration of Chemotherapy].
Maemura K; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
Gan To Kagaku Ryoho; 2024 Jan; 51(1):93-95. PubMed ID: 38247103
[TBL] [Abstract][Full Text] [Related]
40. Suppression of inflammation during cell-free concentrated ascites reinfusion therapy using a blood purification device.
Ohashi A; Nakai S; Hori H; Yamada S; Kato M; Koide S; Hayashi H; Tsuboi N; Inaguma D; Hasegawa M; Yuzawa Y
Ther Apher Dial; 2020 Oct; 24(5):511-515. PubMed ID: 32526100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
